748 related articles for article (PubMed ID: 24583503)
1. Therapeutic role of anakinra, an interleukin-1 receptor antagonist, in the management of secondary hemophagocytic lymphohistiocytosis/sepsis/multiple organ dysfunction/macrophage activating syndrome in critically ill children*.
Rajasekaran S; Kruse K; Kovey K; Davis AT; Hassan NE; Ndika AN; Zuiderveen S; Birmingham J
Pediatr Crit Care Med; 2014 Jun; 15(5):401-8. PubMed ID: 24583503
[TBL] [Abstract][Full Text] [Related]
2. High-Volume Hemofiltration in Critically Ill Patients With Secondary Hemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome: A Prospective Study in the PICU.
Cui Y; Zhang YC; Kang YL; Ren YQ; Miao HJ; Wang F
Pediatr Crit Care Med; 2016 Oct; 17(10):e437-e443. PubMed ID: 27487914
[TBL] [Abstract][Full Text] [Related]
3. A Personalized Diagnostic and Treatment Approach for Macrophage Activation Syndrome and Secondary Hemophagocytic Lymphohistiocytosis in Adults.
Kumar B; Aleem S; Saleh H; Petts J; Ballas ZK
J Clin Immunol; 2017 Oct; 37(7):638-643. PubMed ID: 28871523
[TBL] [Abstract][Full Text] [Related]
4. Benefit of Anakinra in Treating Pediatric Secondary Hemophagocytic Lymphohistiocytosis.
Eloseily EM; Weiser P; Crayne CB; Haines H; Mannion ML; Stoll ML; Beukelman T; Atkinson TP; Cron RQ
Arthritis Rheumatol; 2020 Feb; 72(2):326-334. PubMed ID: 31513353
[TBL] [Abstract][Full Text] [Related]
5. Continuous intravenous anakinra for treating severe secondary haemophagocytic lymphohistiocytosis/macrophage activation syndrome in critically ill children.
Charlesworth JEG; Wilson S; Qureshi A; Blanco E; Mitchell A; Segal S; Kelly D; Weitz J; O'Shea D; Bailey K; Kavirayani A
Pediatr Blood Cancer; 2021 Sep; 68(9):e29102. PubMed ID: 34114322
[TBL] [Abstract][Full Text] [Related]
6. Interleukin 1 Receptor Antagonist Anakinra, Intravenous Immunoglobulin, and Corticosteroids in the Management of Critically Ill Adult Patients With Hemophagocytic Lymphohistiocytosis.
Wohlfarth P; Agis H; Gualdoni GA; Weber J; Staudinger T; Schellongowski P; Robak O
J Intensive Care Med; 2019 Sep; 34(9):723-731. PubMed ID: 28631531
[TBL] [Abstract][Full Text] [Related]
7. Experience with hemophagocytic lymphohistiocytosis/macrophage activation syndrome at a single institution.
Gupta AA; Tyrrell P; Valani R; Benseler S; Abdelhaleem M; Weitzman S
J Pediatr Hematol Oncol; 2009 Feb; 31(2):81-4. PubMed ID: 19194188
[TBL] [Abstract][Full Text] [Related]
8. Plasma exchange, methylprednisolone, IV immune globulin, and now anakinra support continued PICU equipoise in management of hyperferritinemia-associated sepsis/multiple organ dysfunction syndrome/macrophage activation syndrome/secondary hemophagocytic lymphohistiocytosis syndrome*.
Simon DW; Aneja R; Carcillo JA; Halstead ES
Pediatr Crit Care Med; 2014 Jun; 15(5):486-8. PubMed ID: 24892479
[No Abstract] [Full Text] [Related]
9. An unusual cause of multiple organ dysfunction syndrome in the pediatric intensive care unit: hemophagocytic lymphohistiocytosis.
Karapinar B; Yilmaz D; Balkan C; Akin M; Ay Y; Kvakli K
Pediatr Crit Care Med; 2009 May; 10(3):285-90. PubMed ID: 19433941
[TBL] [Abstract][Full Text] [Related]
10. Hypofibrinogenemia Is Associated With Poor Outcome and Secondary Hemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome in Pediatric Severe Sepsis.
Signoff JK; Fitzgerald JC; Teachey DT; Balamuth F; Weiss SL
Pediatr Crit Care Med; 2018 May; 19(5):397-405. PubMed ID: 29470247
[TBL] [Abstract][Full Text] [Related]
11. The use of anakinra in the treatment of secondary hemophagocytic lymphohistiocytosis.
Bami S; Vagrecha A; Soberman D; Badawi M; Cannone D; Lipton JM; Cron RQ; Levy CF
Pediatr Blood Cancer; 2020 Nov; 67(11):e28581. PubMed ID: 32725881
[TBL] [Abstract][Full Text] [Related]
12. Hemophagocytic Lymphohistiocytosis in a PICU of a Developing Economy: Clinical Profile, Intensive Care Needs, Outcome, and Predictors of Mortality.
Parajuli B; Angurana SK; Awasthi P; Nallasamy K; Baranwal A; Bansal A; Bansal D; Rawat A; Varma N; Jayashree M
Pediatr Crit Care Med; 2021 Jan; 22(1):e44-e57. PubMed ID: 33031348
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-1 Receptor Blockade Is Associated With Reduced Mortality in Sepsis Patients With Features of Macrophage Activation Syndrome: Reanalysis of a Prior Phase III Trial.
Shakoory B; Carcillo JA; Chatham WW; Amdur RL; Zhao H; Dinarello CA; Cron RQ; Opal SM
Crit Care Med; 2016 Feb; 44(2):275-81. PubMed ID: 26584195
[TBL] [Abstract][Full Text] [Related]
14. Secondary hemophagocytic lymphohistiocytosis and severe sepsis/ systemic inflammatory response syndrome/multiorgan dysfunction syndrome/macrophage activation syndrome share common intermediate phenotypes on a spectrum of inflammation.
Castillo L; Carcillo J
Pediatr Crit Care Med; 2009 May; 10(3):387-92. PubMed ID: 19325510
[TBL] [Abstract][Full Text] [Related]
15. Hyperferritinemia in the critically ill child with secondary hemophagocytic lymphohistiocytosis/sepsis/multiple organ dysfunction syndrome/macrophage activation syndrome: what is the treatment?
Demirkol D; Yildizdas D; Bayrakci B; Karapinar B; Kendirli T; Koroglu TF; Dursun O; Erkek N; Gedik H; Citak A; Kesici S; Karabocuoglu M; Carcillo JA;
Crit Care; 2012 Dec; 16(2):R52. PubMed ID: 22715953
[TBL] [Abstract][Full Text] [Related]
16. The Use of Ferritin to Identify Critically Ill Patients With Secondary Hemophagocytic Lymphohistiocytosis.
Grangé S; Buchonnet G; Besnier E; Artaud-Macari E; Beduneau G; Carpentier D; Dehay J; Girault C; Marchalot A; Guerrot D; Tamion F
Crit Care Med; 2016 Nov; 44(11):e1045-e1053. PubMed ID: 27441901
[TBL] [Abstract][Full Text] [Related]
17. Intravenous administration of anakinra in children with macrophage activation syndrome.
Phadke O; Rouster-Stevens K; Giannopoulos H; Chandrakasan S; Prahalad S
Pediatr Rheumatol Online J; 2021 Jun; 19(1):98. PubMed ID: 34187503
[TBL] [Abstract][Full Text] [Related]
18. Severe hemorrhagic coagulopathy with hemophagocytic lymphohistiocytosis secondary to Epstein-Barr virus-associated T-cell lymphoproliferative disorder.
Nawathe PA; Ravindranath TM; Satwani P; Baird JS
Pediatr Crit Care Med; 2013 May; 14(4):e176-81. PubMed ID: 23439459
[TBL] [Abstract][Full Text] [Related]
19. Rapid and sustained remission of systemic juvenile idiopathic arthritis-associated macrophage activation syndrome through treatment with anakinra and corticosteroids.
Bruck N; Suttorp M; Kabus M; Heubner G; Gahr M; Pessler F
J Clin Rheumatol; 2011 Jan; 17(1):23-7. PubMed ID: 21169853
[TBL] [Abstract][Full Text] [Related]
20. Outcomes Analysis of Children Diagnosed With Hemophagocytic Lymphohistiocytosis in the PICU.
Gregory J; Greenberg J; Basu S
Pediatr Crit Care Med; 2019 Apr; 20(4):e185-e190. PubMed ID: 30520798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
